ARCHIVES

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

September 3, 1976

Gene Expression Test Accurately Classifies “Inconclusive” Samples

July 27, 2012

Sebelius: Congress Harming Nation’s Investment in Science

October 4, 2013

Vanderbilt Lung Cancer Trial For Never Smokers Online

September 25, 2009

OMB Backs Down, Releases New Construction Funds After Ruling They Are “Alteration, Renovation”

December 13, 1974

In Brief: Centers Awarded Gifts; Georgetown Launches $40m Campaign; Herberman Named To PA Board

February 1, 1991